Pages that link to "Q65017091"
Jump to navigation
Jump to search
The following pages link to Arne Yndestad (Q65017091):
Displaying 50 items.
- The complement system and toll-like receptors as integrated players in the pathophysiology of atherosclerosis (Q28083548) (← links)
- Interleukin-7-mediated inflammation in unstable angina: possible role of chemokines and platelets (Q28195974) (← links)
- Increased levels of neutrophil-activating peptide-2 in acute coronary syndromes: possible role of platelet-mediated vascular inflammation (Q28200764) (← links)
- Toll-like receptor 9-activation during onset of myocardial ischemia does not influence infarct extension (Q28541982) (← links)
- Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure (Q28575465) (← links)
- The early transcriptomic response to interleukin 1β and interleukin 33 in rat neonatal cardiomyocytes (Q28578898) (← links)
- Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure (Q30611192) (← links)
- The effect of rosuvastatin on inflammation, matrix turnover and left ventricular remodeling in dilated cardiomyopathy: a randomized, controlled trial (Q31152172) (← links)
- Enhanced levels of urokinase plasminogen activator and its soluble receptor in common variable immunodeficiency (Q33383387) (← links)
- Toll-Like Receptor 9 Promotes Survival in SERCA2a KO Heart Failure Mice (Q33604761) (← links)
- Wnt5a is associated with right ventricular dysfunction and adverse outcome in dilated cardiomyopathy (Q33799421) (← links)
- Lack of chemokine signaling through CXCR5 causes increased mortality, ventricular dilatation and deranged matrix during cardiac pressure overload (Q33886486) (← links)
- Toll-like receptor 9 mediated responses in cardiac fibroblasts (Q34050642) (← links)
- The homeostatic chemokine CCL21 predicts mortality and may play a pathogenic role in heart failure (Q34200352) (← links)
- Increased levels of inflammatory cytokines and endothelin-1 in alveolar macrophages from patients with chronic heart failure (Q34277432) (← links)
- The homeostatic chemokine CCL21 predicts mortality in aortic stenosis patients and modulates left ventricular remodeling (Q34513415) (← links)
- CCL21 is associated with fatal outcomes in chronic heart failure: data from CORONA and GISSI-HF trials (Q34619812) (← links)
- Association of ficolin-3 with severity and outcome of chronic heart failure (Q34676160) (← links)
- Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure (Q35406034) (← links)
- Expression of matrix metalloproteinases in patients with Wegener's granulomatosis (Q35553707) (← links)
- Secreted Frizzled Related Protein 3 in Chronic Heart Failure: Analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA). (Q35750462) (← links)
- Inflammation and chronic heart failure-potential therapeutic role of intravenous immunoglobulin (Q35756990) (← links)
- Therapeutic potential of anticytokine therapy in congestive heart failure (Q35768272) (← links)
- Activin A levels are associated with abnormal glucose regulation in patients with myocardial infarction: potential counteracting effects of activin A on inflammation (Q35797015) (← links)
- Sustained Toll-Like Receptor 9 Activation Promotes Systemic and Cardiac Inflammation, and Aggravates Diastolic Heart Failure in SERCA2a KO Mice (Q35804806) (← links)
- Agents targeting inflammation in heart failure (Q36145827) (← links)
- Inflammatory and anti-inflammatory cytokines in chronic heart failure: potential therapeutic implications (Q36198484) (← links)
- Potential role for immunomodulatory therapy in atherosclerotic plaque stabilisation (Q36283698) (← links)
- Inflammation in coronary artery disease: potential role for immunomodulatory therapy (Q36314881) (← links)
- Anti-inflammatory trials in chronic heart failure. (Q36425459) (← links)
- Systemic inflammation in heart failure--the whys and wherefores (Q36526913) (← links)
- The role of intravenous immunoglobulin in the treatment of chronic heart failure (Q36558817) (← links)
- Increased Serum Levels of LIGHT/TNFSF14 in Nonalcoholic Fatty Liver Disease: Possible Role in Hepatic Inflammation (Q36752011) (← links)
- Role of inflammation in the progression of heart failure (Q36806972) (← links)
- Potential mechanisms of benefit with thalidomide in chronic heart failure (Q36822365) (← links)
- NLRP3 Inflammasome Expression and Activation in Human Atherosclerosis (Q36956703) (← links)
- The role of statins in heart failure (Q37000806) (← links)
- The complex role of T-cell-based immunity in atherosclerosis (Q37167783) (← links)
- Chemokines and cardiovascular risk (Q37231421) (← links)
- Activated platelets and atherosclerosis (Q37786647) (← links)
- Tumor necrosis factor superfamily molecules in acute coronary syndromes (Q37805514) (← links)
- Activin A in Nonalcoholic Fatty Liver Disease (Q37847440) (← links)
- TNF revisited: osteoprotegerin and TNF-related molecules in heart failure (Q37997644) (← links)
- Inflammatory cytokines in heart failure: mediators and markers (Q38018808) (← links)
- Heart failure biomarkers: focus on interleukin-1 receptor-like 1-based blood tests (Q38030553) (← links)
- Interleukin-6 signaling, soluble glycoprotein 130, and inflammation in heart failure (Q38183314) (← links)
- A vital role for complement in heart disease (Q38231108) (← links)
- Inflammatory cytokines as biomarkers in heart failure (Q38246972) (← links)
- Leukaemia inhibitory factor alters expression of genes involved in rat cardiomyocyte energy metabolism (Q38345676) (← links)
- The colon mitosis-inhibitor pyroglutamyl-histidyl-glycine alters expression of immediate-early cancer-related genes in HT-29 cells (Q38353387) (← links)